Chief Business Officer & Head of Finance
Véronique Riethuisen brings over 25 years of experience in global business development, M&A and alliance management leadership to Cedilla. Most recently, Véronique served as Senior Vice President, Global Business Development and Strategic Alliance Management at Ipsen where she helped build Ipsen’s rare disease franchise by acquiring and licensing multiple innovative assets for the treatment of fibrodysplasia ossificans progressiva. Prior to Ipsen, Véronique was Vice President, Head of Global Transactions at Takeda where she led the BD team that transformed the company’s gastrointestinal and regenerative medicine portfolios. Earlier, Véronique held various business development, M&A and alliance management roles of increasing responsibility at Pfizer, Teva, Bristol Myers Squibb and Monsanto. Véronique currently serves as an Executive Coach for the Mass NextGen program mentoring first-time female chief executive officers, and she also teaches a Business Development Fundamentals course offered annually in conjunction with the BIO Annual Conference. Véronique holds a bachelor and master’s degree in Applied Economics from the University of Brussels (ULB), Belgium.